בינוקריט 3000 יחבל  0.3 מל ישראל - עברית - Ministry of Health

בינוקריט 3000 יחבל 0.3 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 3000 iu / 0.3 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

בינוקריט 40000 יחבל  1 מל ישראל - עברית - Ministry of Health

בינוקריט 40000 יחבל 1 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 40000 iu / 1 ml - erythropoietin - erythropoietin - treatment of symptomatic anaemia associated with chronic renal failure (crf) in adult and paediatric patients:- treatment of anaemia associated with chronic renal failure in paediatric and adult patients on haemodialysis and adult patients on peritoneal dialysis.- treatment of severe anaemia of renal origin accompanied by clinical symptoms in adult patients with renal insufficiency not yet undergoing dialysis. treatment of anaemia and reduction of transfusion requirements in adult patients receiving chemotherapy for solid tumours, malignant lymphoma or multiple myeloma, and at risk of transfusion as assessed by the patient's general status (e.g. cardiovascular status, pre existing anaemia at the start of chemotherapy). binocrit can be used to increase the yield of autologous blood from patients in a predonation programme. its use in this indication must be balanced against the reported risk of thromboembolic events. treatment should only be given to non-iron deficient patients with moderate anaemia (haemoglob

בינוקריט 8000 יחבל  0.8 מל ישראל - עברית - Ministry of Health

בינוקריט 8000 יחבל 0.8 מל

novartis israel ltd - epoetin alfa - תמיסה להזרקה - epoetin alfa 8000 iu / 0.8 ml - erythropoietin

מינוקסי 2 ישראל - עברית - Ministry of Health

מינוקסי 2

trima israel pharmaceutical products maabarot ltd - minoxidil - תמיסה - minoxidil 2 %w/v - minoxidil - minoxidil - androgenetic alopecia in males and females.

מינוקסי 5 ישראל - עברית - Ministry of Health

מינוקסי 5

trima israel pharmaceutical products maabarot ltd - minoxidil - תמיסה - minoxidil 5 % - minoxidil - minoxidil - androgenetic alopecia in males .

ורה פאנטן תחליב טיפולי ישראל - עברית - Ministry of Health

ורה פאנטן תחליב טיפולי

אס.טי. הלתליין בעמ - להרגעת גירויים ואדמומיות העור כתוצאה מיובש או כוויות שמש קלות

יורוקינאז מדאק 10000 IU ישראל - עברית - Ministry of Health

יורוקינאז מדאק 10000 iu

tzamal bio-pharma ltd - urokinase - אבקה להכנת תמיסה לזריקה - urokinase 10000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.

יורוקינאז מדאק 50000 IU ישראל - עברית - Ministry of Health

יורוקינאז מדאק 50000 iu

tzamal bio-pharma ltd - urokinase - אבקה להכנת תמיסה לזריקה - urokinase 50000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.

יורוקינאז מדאק 100000 IU ישראל - עברית - Ministry of Health

יורוקינאז מדאק 100000 iu

tzamal bio-pharma ltd - urokinase - אבקה להכנת תמיסה לזריקה - urokinase 100,000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.

יורוקינאז מדאק 250000 IU ישראל - עברית - Ministry of Health

יורוקינאז מדאק 250000 iu

tzamal bio-pharma ltd - urokinase - אבקה להכנת תמיסה לזריקה - urokinase 250000 iu - urokinase - urokinase - peripheral arterial thrombosis ;acute and subacute deep vein thrombosis ; acute diagnostically confirmed pulmonary embolism, in particular when associated with unstable haemodynamic status ; thrombosed arteriovenous shunt.